Leiomyosarcoma - 28 Studies Found
Recruiting |
: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum :
: 2013-07-17 : Drug: Nilotinib-adriamycin The nilotinib-adriamycin combination will be given in 4 cycles of 21 days. In |
Completed |
: Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus :
|
Completed |
: Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus :
|
Completed |
: Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas :
: 2011-08-29 : Drug: Gemcitabine + Trabectedin Combination therapy of gemcitabine and trabectedin |
Completed |
: A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer :
: 2003-05-16 :
|
RECRUITING |
: Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working : Locally Advanced Uterine Corpus Leiomyosarcoma : 2024-05-09 : Undergo collection of blood samples |
RECRUITING |
: Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma : Leiomyosarcoma : 2024-05-09 : Intravenous Infusion |
RECRUITING |
: Localized Leiomyosarcoma Biomarker Protocol : Leiomyosarcoma : 2024-05-09 : Blood and tissue will be collected and analyzed for detection of ctDNA and genetic change |